ARS Pharmaceuticals Stock (NASDAQ: SPRY) stock price, news, charts, stock research, profile.
Open | $10.72 |
Close | $10.32 |
Volume / Avg. | 467.31K / 572.71K |
Day Range | 10.29 - 10.85 |
52 Wk Range | 2.55 - 11.90 |
Market Cap | $1.02B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 13.39% |
Days to Cover | 6.69 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ARS Pharmaceuticals (NASDAQ:SPRY) through any online brokerage.
Other companies in ARS Pharmaceuticals’s space includes: Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Cogent Biosciences (NASDAQ:COGT) and Centessa Pharmaceuticals (NASDAQ:CNTA).
There is no analysis for ARS Pharmaceuticals.
ARS Pharmaceuticals has a consensus price target of $17.00.
The stock price for ARS Pharmaceuticals (NASDAQ: SPRY) is $10.51 last updated July 23, 2024 at 5:06 PM EDT.
There are no upcoming dividends for ARS Pharmaceuticals.
ARS Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for ARS Pharmaceuticals.
ARS Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.